ClinicalTrials.Veeva

Menu

Middle East African Registry Women CardioVascular Disease (MEA-WCVD)

T

Tunisian Society of Cardiology and Cardiovascular Surgery

Status

Enrolling

Conditions

Ischemic Heart Disease
Atrial Fibrillation
Valvular Heart Disease
Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT05869214
WCVD012023

Details and patient eligibility

About

The MEA cardiology societies have joined forces to tackle the issue by establishing a tangible real-world data registry in every MEA country. This endeavor has resulted in the development of a multicenter registry called MEA-WCVD, which is being sponsored by each national cardiology society from participating countries. All data gathered will be consolidated into a singular registry for thorough analysis. Country specific analysis will be performed.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All incomers in Cardiovascular (CV) diseases in hospital or out hospital facilities with one of the 4 diagnosis (Heart Failure (HF), Atrial fibrillation (AF), Valvular Heart disease (VHD), ischemic heart disease (IHD)
  • Age over 18 years old
  • Men and Women
  • Signature of consent form

Exclusion criteria

Patients with diseases other than the 4 previously mentioned in inclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Salem Abdessalem, Dr; Selma Charfeddine, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems